Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sin Nombre virus | 2 | 2019 | 3 | 1.01 | Why? |
| Hantavirus Pulmonary Syndrome | 2 | 2019 | 17 | 0.99 | Why? |
| Triazoles | 4 | 2018 | 440 | 0.91 | Why? |
| Nitriles | 4 | 2018 | 1053 | 0.87 | Why? |
| Invasive Fungal Infections | 3 | 2018 | 274 | 0.81 | Why? |
| Pyridines | 4 | 2018 | 680 | 0.81 | Why? |
| Proctocolitis | 1 | 2018 | 2 | 0.78 | Why? |
| Serratia Infections | 1 | 2018 | 12 | 0.77 | Why? |
| Serratia marcescens | 1 | 2018 | 38 | 0.75 | Why? |
| Proctitis | 1 | 2018 | 16 | 0.75 | Why? |
| Hantavirus | 1 | 2019 | 63 | 0.74 | Why? |
| Delayed Diagnosis | 2 | 2018 | 1529 | 0.68 | Why? |
| Antifungal Agents | 5 | 2018 | 1828 | 0.60 | Why? |
| Heterosexuality | 1 | 2016 | 148 | 0.60 | Why? |
| Israel | 13 | 2021 | 2751 | 0.54 | Why? |
| Heart Transplantation | 1 | 2021 | 1293 | 0.42 | Why? |
| Sexually Transmitted Diseases | 1 | 2018 | 694 | 0.41 | Why? |
| Equipment Contamination | 1 | 2018 | 1308 | 0.39 | Why? |
| Salmonella Infections, Animal | 2 | 2019 | 18 | 0.38 | Why? |
| Pneumococcal Vaccines | 3 | 2018 | 571 | 0.35 | Why? |
| Salmonella enterica | 2 | 2017 | 39 | 0.35 | Why? |
| Salmonella typhimurium | 2 | 2019 | 81 | 0.35 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 2 | 2018 | 64 | 0.34 | Why? |
| Waste Water | 1 | 2018 | 2185 | 0.34 | Why? |
| HIV Reverse Transcriptase | 2 | 2018 | 104 | 0.34 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.32 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.31 | Why? |
| Tumor Suppressor Protein p53 | 2 | 2018 | 310 | 0.28 | Why? |
| HIV Infections | 3 | 2021 | 11620 | 0.28 | Why? |
| Bacterial Proteins | 3 | 2019 | 1318 | 0.28 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.25 | Why? |
| Gene Expression Regulation, Bacterial | 3 | 2019 | 143 | 0.24 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.24 | Why? |
| Kidney Transplantation | 1 | 2021 | 5397 | 0.22 | Why? |
| Pneumococcal Infections | 2 | 2018 | 562 | 0.22 | Why? |
| Staphylococcus aureus | 2 | 2018 | 844 | 0.22 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.21 | Why? |
| Clostridium Infections | 2 | 2018 | 595 | 0.20 | Why? |
| DNA Replication | 2 | 2018 | 121 | 0.20 | Why? |
| Administration, Intravenous | 3 | 2018 | 1115 | 0.20 | Why? |
| Mycophenolic Acid | 1 | 2021 | 383 | 0.20 | Why? |
| Folic Acid | 1 | 2021 | 172 | 0.19 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.19 | Why? |
| Electrophoresis, Gel, Pulsed-Field | 1 | 2018 | 78 | 0.19 | Why? |
| Atovaquone | 1 | 2018 | 19 | 0.19 | Why? |
| Poliovirus Vaccines | 1 | 2019 | 85 | 0.19 | Why? |
| Proguanil | 1 | 2018 | 23 | 0.19 | Why? |
| Pharyngeal Diseases | 1 | 2019 | 56 | 0.19 | Why? |
| Meningitis, Pneumococcal | 1 | 2018 | 35 | 0.18 | Why? |
| Fimbriae, Bacterial | 1 | 2017 | 14 | 0.18 | Why? |
| Poliovirus | 1 | 2019 | 109 | 0.18 | Why? |
| Staphylococcal Infections | 2 | 2018 | 1099 | 0.18 | Why? |
| DNA Repair | 1 | 2018 | 114 | 0.17 | Why? |
| Uracil | 1 | 2018 | 101 | 0.17 | Why? |
| Carrier State | 3 | 2018 | 2100 | 0.17 | Why? |
| Respiratory Insufficiency | 1 | 2019 | 7301 | 0.17 | Why? |
| Salmonella Infections | 1 | 2017 | 82 | 0.16 | Why? |
| Voriconazole | 1 | 2018 | 206 | 0.16 | Why? |
| Salmonella paratyphi A | 1 | 2016 | 22 | 0.16 | Why? |
| Malaria, Vivax | 1 | 2018 | 152 | 0.16 | Why? |
| Ribonucleotides | 1 | 2017 | 96 | 0.16 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.16 | Why? |
| Virulence | 3 | 2019 | 2172 | 0.16 | Why? |
| Hospitals, Special | 1 | 2021 | 523 | 0.16 | Why? |
| CD4 Lymphocyte Count | 1 | 2021 | 1517 | 0.15 | Why? |
| Secondary Prevention | 2 | 2018 | 762 | 0.15 | Why? |
| Poliomyelitis | 1 | 2019 | 263 | 0.14 | Why? |
| Middle Aged | 25 | 2021 | 270681 | 0.14 | Why? |
| HIV-1 | 2 | 2021 | 3365 | 0.14 | Why? |
| Male | 28 | 2021 | 367725 | 0.13 | Why? |
| Aged | 21 | 2021 | 215776 | 0.13 | Why? |
| Adult | 22 | 2021 | 244371 | 0.13 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2012 | 72 | 0.13 | Why? |
| Interleukin-17 | 1 | 2018 | 602 | 0.12 | Why? |
| Ampicillin | 1 | 2012 | 73 | 0.12 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.12 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.12 | Why? |
| Image Processing, Computer-Assisted | 1 | 2021 | 1383 | 0.12 | Why? |
| Dose-Response Relationship, Drug | 1 | 2021 | 3776 | 0.12 | Why? |
| Minocycline | 1 | 2012 | 101 | 0.12 | Why? |
| Skin Diseases, Bacterial | 1 | 2012 | 105 | 0.11 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.11 | Why? |
| Anaphylaxis | 1 | 2021 | 940 | 0.11 | Why? |
| Skin Diseases, Infectious | 1 | 2012 | 77 | 0.11 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 1261 | 0.11 | Why? |
| Female | 26 | 2021 | 380317 | 0.11 | Why? |
| Intestines | 1 | 2017 | 817 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Graft Rejection | 1 | 2021 | 1766 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Travel-Related Illness | 1 | 2018 | 1357 | 0.11 | Why? |
| Humans | 39 | 2021 | 930598 | 0.10 | Why? |
| Oropharynx | 1 | 2019 | 1581 | 0.10 | Why? |
| Mucormycosis | 2 | 2018 | 832 | 0.10 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.10 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.09 | Why? |
| Immunity, Herd | 1 | 2017 | 1011 | 0.09 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.09 | Why? |
| Gene Expression | 1 | 2019 | 3332 | 0.09 | Why? |
| Anti-HIV Agents | 1 | 2021 | 2209 | 0.09 | Why? |
| Antibodies, Monoclonal | 2 | 2018 | 8041 | 0.09 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.08 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.08 | Why? |
| Mice, Inbred C57BL | 4 | 2019 | 5542 | 0.08 | Why? |
| Antimalarials | 1 | 2018 | 2505 | 0.07 | Why? |
| Emergency Service, Hospital | 2 | 2021 | 14232 | 0.07 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.07 | Why? |
| Multivariate Analysis | 1 | 2016 | 5440 | 0.07 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| Triage | 2 | 2021 | 7151 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Fungi | 2 | 2018 | 471 | 0.06 | Why? |
| Heart Diseases | 1 | 2021 | 3503 | 0.06 | Why? |
| Aspergillosis | 2 | 2018 | 264 | 0.06 | Why? |
| Species Specificity | 2 | 2018 | 1356 | 0.06 | Why? |
| Travel | 2 | 2019 | 7220 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
| Infection Control | 3 | 2021 | 23131 | 0.06 | Why? |
| Virus Shedding | 1 | 2019 | 5834 | 0.06 | Why? |
| Folic Acid Deficiency | 1 | 2021 | 22 | 0.06 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.06 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.05 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.05 | Why? |
| Regulon | 1 | 2019 | 5 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| RNA, Bacterial | 1 | 2019 | 116 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2003 | 12361 | 0.05 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.05 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.05 | Why? |
| Metronidazole | 1 | 2018 | 59 | 0.05 | Why? |
| Umbilicus | 1 | 2017 | 12 | 0.05 | Why? |
| Antigens, Protozoan | 1 | 2018 | 121 | 0.04 | Why? |
| Ear | 1 | 2017 | 51 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| APACHE | 1 | 2020 | 682 | 0.04 | Why? |
| Mice | 4 | 2019 | 21357 | 0.04 | Why? |
| Vietnam | 1 | 2003 | 1665 | 0.04 | Why? |
| Genetic Drift | 1 | 2017 | 54 | 0.04 | Why? |
| Mucorales | 1 | 2018 | 92 | 0.04 | Why? |
| Microscopy, Atomic Force | 1 | 2017 | 118 | 0.04 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.04 | Why? |
| Multigene Family | 1 | 2017 | 377 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.04 | Why? |
| Meningitis, Bacterial | 1 | 2017 | 111 | 0.04 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2017 | 6049 | 0.04 | Why? |
| HeLa Cells | 1 | 2019 | 1303 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2019 | 1236 | 0.04 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2017 | 605 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Infant | 4 | 2019 | 30274 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2017 | 640 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.04 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.04 | Why? |
| Trans-Activators | 1 | 2016 | 170 | 0.03 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.03 | Why? |
| Child, Preschool | 4 | 2019 | 36283 | 0.03 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Rectum | 1 | 2017 | 495 | 0.03 | Why? |
| Phylogeography | 1 | 2018 | 824 | 0.03 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.03 | Why? |
| Fecal Microbiota Transplantation | 1 | 2018 | 372 | 0.03 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.03 | Why? |
| Animals | 6 | 2019 | 78931 | 0.03 | Why? |
| Sulbactam | 1 | 2012 | 37 | 0.03 | Why? |
| Time Factors | 1 | 2016 | 31397 | 0.03 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.03 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 511 | 0.03 | Why? |
| Th17 Cells | 1 | 2018 | 657 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2016 | 1036 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Ships | 1 | 2020 | 1046 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2016 | 15421 | 0.03 | Why? |
| United States | 1 | 2019 | 46150 | 0.03 | Why? |
| Chickens | 1 | 2017 | 1010 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.03 | Why? |
| Workflow | 1 | 2021 | 2373 | 0.03 | Why? |
| Sequence Alignment | 1 | 2017 | 2109 | 0.03 | Why? |
| Nose | 1 | 2017 | 1093 | 0.03 | Why? |
| Hypersensitivity | 1 | 2021 | 1137 | 0.03 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2018 | 1218 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.03 | Why? |
| Smartphone | 1 | 2021 | 1840 | 0.03 | Why? |
| World Health Organization | 1 | 2003 | 4213 | 0.03 | Why? |
| Canada | 1 | 2003 | 6018 | 0.02 | Why? |
| Dogs | 1 | 2017 | 2529 | 0.02 | Why? |
| Blood Pressure | 1 | 2021 | 2198 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Liver | 1 | 2021 | 4007 | 0.02 | Why? |
| Infant, Newborn | 2 | 2019 | 23105 | 0.02 | Why? |
| Mothers | 1 | 2017 | 1624 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.02 | Why? |
| Models, Molecular | 1 | 2017 | 7616 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2019 | 10998 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11367 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| SARS Virus | 1 | 2003 | 13021 | 0.01 | Why? |
| Nasopharynx | 1 | 2018 | 10224 | 0.01 | Why? |
| Child | 2 | 2019 | 70012 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2003 | 22116 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
| China | 1 | 2003 | 50654 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Cytokines | 1 | 2016 | 15010 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |